Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07780357) titled 'HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B' on Aug. 19.

Study Type: Observational

Primary Sponsor: Beijing Friendship Hospital

Condition: Hepatocellular Carcinoma (HCC)

Intervention: Other: No intervention (observational study)

Recruitment Status: Not recruiting

Date of First Enrollment: August 20, 2026

Target Sample Size: 2000

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07780357

Disclaimer: Curated by HT Syndication....